SJ Corporation's subsidiary guarantees up to ₹42.5 Cr of group debt — about 70% of one quarter's revenue
The wholly-owned subsidiary will backstop up to ₹42.5 Cr of credit facilities for group company Fishfa Biogenics. SJ Corp is not a party; the stock sits at its 52-week high.
₹200.60
Nov 16 · the 52-week high
SMALL-CAP
by market cap ≈ ₹869.7 Cr
₹42.5 Cr
≈4.9% of market cap
67.52%
13.65% as of Jun 30, 2026
₹60.40 Cr
consolidated · PAT ₹2.21 Cr
+225%
low ₹61.75 · Jan 27, 2026
On the evening of November 17, SJ Corporation told the exchange that its wholly-owned subsidiary will stand behind up to ₹42.5 crore of credit facilities for a group company — while noting, in the same filing, that the listed company itself "is not a party to this guarantee." It is the second outbound commitment disclosed from the subsidiary in under three weeks, and it arrives with the stock at its 52-week high after an almost uninterrupted climb of about ten months from the late-January low, under promoters who completed their open offer in August.
A ₹42.5 Cr backstop, routed through the subsidiary
Board approves: Fisha Rubber to guarantee up to ₹42.5 Cr of credit facilities for Fishfa Biogenics
At a board meeting held on November 17, 2026 (3:00–3:30 PM, on shorter notice per the outcome filing), SJ Corporation's board considered and approved a corporate guarantee by Fisha Rubber Limited (FRL), its wholly-owned subsidiary, so that Fishfa Biogenics Limited (FBL) can avail credit facilities up to a maximum principal amount of INR 42,50,00,000 — i.e. ₹42.5 crore. The filing states that SJ Corporation is not a party to the guarantee, that the promoter/promoter group/group companies have an interest in the transaction, and that it was carried out on an arm's-length basis.
Read:The annexure's entire stated impact on the listed entity is one line: the guarantee "has been provided to the group company." The filing names no lender, no tenor, no security and no financials for FBL. What shareholders can see is the cap — ₹42.5 Cr — and the route: through the subsidiary rather than the listed parent.
BSE filing, Nov 17, 2026 — Regulation 30 disclosureThe disclosure reached the exchange twice within two minutes — at 15:41 as a board-meeting outcome and at 15:43 as a Regulation 30 disclosure, with identical content. One detail the filings do not reconcile: the November 17 documents name the guarantor "Fisha Rubber Limited", while the October 30 filings call the wholly-owned subsidiary "Fishfa Rubbers Limited" — both abbreviated FRL, both described as the wholly-owned subsidiary of SJ Corporation.
Scale is where the filing earns attention. Against the numbers in this dataset, ₹42.5 Cr is about 4.9% of the ≈₹869.7 Cr market capitalisation (4.34 crore shares at the ₹200.60 last close), roughly 70% of the ₹60.40 Cr consolidated revenue the group reported for Q2 FY27, and more than eleven times the ₹3.75 Cr consolidated net profit of the first half (₹1.54 Cr in Q1 plus ₹2.21 Cr in Q2). A guarantee is a contingent liability — no cash moves unless FBL fails to service the facility — but if invoked near the cap, it would land on a group that earned ₹2.21 Cr of consolidated profit last quarter. That sizing is inference from the disclosed cap; the filing itself discloses no probability of invocation, no tenor and no security.
FRL's second outbound commitment in three weeks
FRL board approves up to ₹7.56 Cr investment in Travia Consultancy Services, Singapore
Fishfa Rubbers Limited (FRL), described in this filing as a material wholly-owned subsidiary of SJ Corporation, approved an investment of an aggregate amount not exceeding INR 7,55,58,885 — i.e. ₹7.56 crore, equivalent to approximately SGD 10,05,000 at SGD 1 = ₹75.18 — in Travia Consultancy Services Pte. Ltd., a private company limited by shares incorporated in Singapore (UEN 202331642K), by way of subscription to ordinary shares.
Read:Taken together with the November 17 guarantee, the subsidiary has disclosed commitments of up to roughly ₹50 Cr outward in under three weeks — one as equity in a Singapore consultancy, one as a contingent backstop of a group company's borrowing.
BSE filing, Oct 30, 2026 — FRL investment in TraviaThe subsidiary matters because it appears to be where the business lives. SJ Corporation's standalone Q2 FY27 revenue was ₹8.27 Cr against ₹60.40 Cr consolidated — the gap, by construction, runs through subsidiaries, and FRL is the one the filings name as material (that attribution is inference; the filings do not break out FRL's own numbers). The listed company is classified under Gems, Jewellery and Watches; the named material subsidiary is a rubber company; the guaranteed entity is a biogenics company; and the new investment is a Singapore consultancy. The filings provide no financials for any of them.
New promoters since August, and a different-looking P&L
A September 24 filing records that Pintu Kanjibhai Kalavadia, Prashant Kanjibhai Kalavadia, Umang Kantilal Savani and Kalpesh Patel completed an open offer on August 3, 2026, pursuant to a share purchase agreement dated January 30, 2026 with sellers Savji D Patel and Ushaben Savjibhai Patel. The shareholding pattern shows the handover: promoter holding was 13.65% (59.2 lakh shares) as of June 30 and 67.52% (2.93 crore shares) as of September 30. On October 3 the board approved the outgoing promoters' reclassification to public category — Savji D Patel holding nil shares, Ushaben Savjibhai Patel 10,00,000 shares (2.31%) — and the application went to BSE on October 7, subject to regulatory approval. The registered office moved from Maharashtra to Rajkot, Gujarat, with the Regional Director's order received on September 24. Pintu Kanjibhai Kalavadia signs the company's filings as Managing Director.
As filed on the exchange. Consolidated reporting in this dataset begins Q4 FY26; earlier quarters are standalone only.
The P&L looks nothing like the old one: consolidated revenue of ₹55.43 Cr in Q1 FY27 and ₹60.40 Cr in Q2 FY27, against ₹7.72 Cr of consolidated revenue in Q4 FY26 and single-digit standalone quarters through FY26. One caveat on attribution: the step-change was already visible in Q1 FY27, the quarter ended June 30, 2026 — when the incoming promoters held just 13.65% and their open offer had yet to complete (it closed on August 3, 2026) — so the revenue shift predates full change of control. Consolidated interest expense was ₹2.04 Cr in Q2 while the standalone interest line shows zero — which suggests, as inference, that the group's borrowings also sit below the listed entity, in the same layer that is now extending the ₹42.5 Cr guarantee. Alongside the Q2 results on October 24, the board declared a first interim dividend of Re 0.05 per equity share of Re 1 face value (5%), payable on or before November 22, 2026.
A near-unbroken climb to the 52-week high
From the 52-week low of ₹61.75 on January 27 to ₹200.60 on November 16 is a gain of about 225%, and the last close is itself the 52-week high. How it got there is as notable as the destination: long runs of small, similar-sized gains on very thin volume — 105 shares traded on November 16, single- and double-digit share counts across early July — with stretches where days pass between listed closes. On activity this thin, the printed price is set by very few shares (inference from the volume data). The guarantee filing landed at 15:43 IST on November 17, after the close; November 18 is the first session in which the market can price it.
The next data points
Nov 18 session
The first close after the after-hours guarantee filing — and whether the thin-volume pattern of the last year persists through it.
Facility details
Any follow-up filing naming the lender, tenor or security behind the ₹42.5 Cr cap, or giving Fishfa Biogenics' financials. None of these are in the November 17 disclosure.
Further group commitments
The subsidiary has disclosed up to ~₹50 Cr of outward commitments since October 30. Watch for additional investments or guarantees routed through it.
Reclassification outcome
BSE's decision on the October 7 application to move Savji D Patel and Ushaben Savjibhai Patel to the public category.
Dividend payment
The first interim dividend of Re 0.05 per share is payable on or before November 22, 2026.
Q3 FY27 results
Whether the ₹55–60 Cr consolidated revenue run-rate and the ~₹2 Cr quarterly consolidated interest line hold, and any disclosure of guarantee invocation.
What the filings establish is narrow but concrete. The board approved a corporate guarantee of up to ₹42.5 crore by the wholly-owned subsidiary for a group company's credit facilities; the listed company says it is not a party; the annexure confirms promoter-group interest and states the transaction is at arm's length. What the filings do not establish matters as much: who the lender is, what Fishfa Biogenics earns or owes, the guarantee's tenor and security, and the subsidiary's own capacity to honour it if called.
The data suggests this is a monitorable rather than a verdict. A contingent liability equal to roughly 70% of a quarter's consolidated revenue, disclosed by a group three months into new ownership, with the stock at its 52-week high on minimal trading volume, is a configuration where subsequent filings — not the headline — will determine whether this was routine group housekeeping or the start of a larger pattern of outward commitments.
Informational and educational content only. Not investment advice.